Patient Characteristics and Clinical Outcomes with Low-Dose Dabigatran

[摘要] Background/aimsDabigatran, an oral direct thrombin inhibitor, is used in patients with non-valvular atrial fibrillation to reduce thromboembolic events. Whereas the 150 mg dosing regimen has been extensively studied in clinical setting, to date, there is no clinical data on the 75 mg (low dose, “LD”) regimen. In this study, we evaluated patient characteristics and clinical outcomes in 49 patients treated with LD dabigatran.

[学科分类] 心脏病和心血管学

[关键词] low-dose dabigatran;atrial fibrillation;dabigatran 75 mg;oral anticoagulant;patient demographics